Frentizole
26130-02-9
0.98%
2026-07-02
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Frentizole Cat No CEI-1341 Product Overview Frentizole, an FDA-approved immunosuppressive drug, as a novel inhibitor of the Aβ-ABAD interaction. CAS No 26130-02-9 Molecular Weight 299.35 Purity 0.98 Storage Store at-20°C Targets Frentizole Molecular Formula C15H13N3O2S Chemical Name 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Solubility Soluble in DMSO Shipping Conditions Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request category Specialty Chemicals(c26) cas_num 26130-02-9 Basic Info-
Product Name:
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea
Other Name:1-(6-methoxy-benzothiazol-2-yl)-3-phenyl-urea; FRENTIZOLE; Frentizol; 1-(6-methoxy-2-benzothiazolyl)-3-phenylurea; 1-(6-methoxybenzo[d]thiazol-2-yl)-3-phenylurea;
CAS No.:26130-02-9
Molecular Formula:C15H13N3O2S
InChIKeys:JHBWYQRKOUBPCA-UHFFFAOYSA-N
Molecular Weight:299.34800
Exact Mass:299.07284784 g/mol
UNII:7EY946394I
DSSTox ID:DTXSID5046279
HScode:2934999090
Categories:
Characteristics-
PSA:
94.98000
XLogP3:4.03550
Density:1.42g/cm3
Refractive Index:1.752
Water Solubility:<0.2 [ug/mL]
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product